CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | Berenson Stephen Director | Exercise or conversion · Restricted Stock Units | −670 | 0 | ||
| 2023-04-27 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-27 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −29,600 | $130.41 | $3.9M | 5,422,346 |
| 2023-04-27 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −9,900 | $131.16 | $1.3M | 5,412,446 |
| 2023-04-27 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −500 | $131.90 | $66K | 5,411,946 |
| 2023-04-27 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 667,155 | ||
| 2023-04-26 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-26 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −7,600 | $130.27 | $990K | 5,444,346 |
| 2023-04-26 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −16,898 | $131.10 | $2.2M | 5,427,448 |
| 2023-04-26 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −9,002 | $132.55 | $1.2M | 5,418,446 |
| 2023-04-26 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −6,500 | $133.93 | $871K | 5,411,946 |
| 2023-04-26 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 707,155 | ||
| 2023-04-20 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-20 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −6,752 | $141.35 | $954K | 5,445,194 |
| 2023-04-20 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −8,780 | $142.24 | $1.2M | 5,436,414 |
| 2023-04-20 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −16,495 | $143.53 | $2.4M | 5,419,919 |
| 2023-04-20 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −7,973 | $144.08 | $1.1M | 5,411,946 |
| 2023-04-20 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 747,155 | ||
| 2023-04-19 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-19 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −11,900 | $141.94 | $1.7M | 5,440,046 |
Page 49 of 66 · 1,314 trades